Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
APR-ED022
- Development stage
- Preclinical
- Lead developer
- APR Applied Pharma Research
- Modality
- Nanoparticles → Drug Delivery Systems, Small Molecules
- Administration
- Ophthalmic, Topical
01
Overview
APR-ED022 is an investigational topical ophthalmic formulation developed by APR Applied Pharma Research (a subsidiary of Relief Therapeutics) for use in eye surgery. The product utilizes the proprietary TEHCLO® Applied Nanotechnology platform, which produces a stable, pH-neutral, super-oxidized solution containing a high concentration of hypochlorous acid (HOCl). This formulation is designed to mimic the natural antimicrobial and anti-inflammatory response of the human immune system, specifically the oxidative burst of neutrophils. In the context of ophthalmic surgery, APR-ED022 is intended to provide perioperative support by preventing infection and managing inflammation, thereby facilitating the healing process. The TEHCLO® technology ensures the stability and biocompatibility of the HOCl solution, making it suitable for sensitive applications such as ocular surgery.
- Other names
- TEHCLO
Beyond the preview
Go deeper on APR-ED022.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on APR-ED022.